Anna K Knight1, Alicia K Smith2, Karen N Conneely3, Philippa Dalach4, Yuk J Loke4, Jeanie L Cheong5, Peter G Davis5, Jeffrey M Craig6, Lex W Doyle7, Christiane Theda5. 1. Genetics and Molecular Biology Program, Emory University, Atlanta, GA. 2. Genetics and Molecular Biology Program, Emory University, Atlanta, GA; Department of Obstetrics and Gynecology, Emory University School of Medicine, Atlanta, GA; Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Atlanta, GA. 3. Department of Human Genetics, Emory University, Atlanta, GA. 4. Murdoch Childrens Research Institute, Melbourne, Victoria, Australia. 5. Murdoch Childrens Research Institute, Melbourne, Victoria, Australia; Department of Obstetrics and Gynecology, University of Melbourne, Melbourne, Victoria, Australia; Neonatal Research, The Royal Women's Hospital, Melbourne, Victoria, Australia. 6. Murdoch Childrens Research Institute, Melbourne, Victoria, Australia; Department of Pediatrics, University of Melbourne, Melbourne, Victoria, Australia; Center for Molecular and Medical Research, School of Medicine Deakin University, Geelong, Victoria, Australia. 7. Murdoch Childrens Research Institute, Melbourne, Victoria, Australia; Department of Obstetrics and Gynecology, University of Melbourne, Melbourne, Victoria, Australia; Neonatal Research, The Royal Women's Hospital, Melbourne, Victoria, Australia; Department of Pediatrics, University of Melbourne, Melbourne, Victoria, Australia.
Abstract
OBJECTIVE: To assess associations between epigenetic maturity of extremely preterm babies (born at less than 28 weeks of gestation), neonatal interventions, and respiratory outcomes, including the administration of surfactant and postnatal corticosteroids, duration of assisted ventilation, and development of bronchopulmonary dysplasia (BPD). STUDY DESIGN: DNA was extracted from neonatal blood spots collected after birth from 143 extremely preterm infants born 1991-1992 in Victoria, Australia and used to determined DNA methylation (DNAm). A DNAm based gestational age was determined using our previously published method. The residual of DNAm gestational age and clinically estimated gestational age (referred to as "gestational age acceleration") was used as a measure to assess developmental maturity. Associations between gestational age acceleration and respiratory interventions and morbidities were determined. RESULTS: Infants with higher gestational age acceleration were less likely to receive surfactant (P = .009) or postnatal corticosteroids (P = .008), had fewer days of assisted ventilation (P = .01), and had less BPD (P = .02). Respiratory measures are known to correlate with gestational age; however, models comparing each with clinically estimated gestational age were improved by the addition of the gestational age acceleration measure in the model. CONCLUSIONS: Gestational age acceleration correlates with respiratory interventions and outcomes of extremely preterm babies. Surfactant and postnatal corticosteroid use, assisted ventilation days, and BPD rates were all lower in babies who were epigenetically more mature than their obstetrically estimated gestational age. This suggests that gestational age acceleration is a clinically relevant metric of developmental maturity.
OBJECTIVE: To assess associations between epigenetic maturity of extremely preterm babies (born at less than 28 weeks of gestation), neonatal interventions, and respiratory outcomes, including the administration of surfactant and postnatal corticosteroids, duration of assisted ventilation, and development of bronchopulmonary dysplasia (BPD). STUDY DESIGN: DNA was extracted from neonatal blood spots collected after birth from 143 extremely preterm infants born 1991-1992 in Victoria, Australia and used to determined DNA methylation (DNAm). A DNAm based gestational age was determined using our previously published method. The residual of DNAm gestational age and clinically estimated gestational age (referred to as "gestational age acceleration") was used as a measure to assess developmental maturity. Associations between gestational age acceleration and respiratory interventions and morbidities were determined. RESULTS:Infants with higher gestational age acceleration were less likely to receive surfactant (P = .009) or postnatal corticosteroids (P = .008), had fewer days of assisted ventilation (P = .01), and had less BPD (P = .02). Respiratory measures are known to correlate with gestational age; however, models comparing each with clinically estimated gestational age were improved by the addition of the gestational age acceleration measure in the model. CONCLUSIONS: Gestational age acceleration correlates with respiratory interventions and outcomes of extremely preterm babies. Surfactant and postnatal corticosteroid use, assisted ventilation days, and BPD rates were all lower in babies who were epigenetically more mature than their obstetrically estimated gestational age. This suggests that gestational age acceleration is a clinically relevant metric of developmental maturity.
Authors: Todd M Everson; Carmen J Marsit; T Michael O'Shea; Amber Burt; Karen Hermetz; Brian S Carter; Jennifer Helderman; Julie A Hofheimer; Elisabeth C McGowan; Charles R Neal; Steven L Pastyrnak; Lynne M Smith; Antoine Soliman; Sheri A DellaGrotta; Lynne M Dansereau; James F Padbury; Barry M Lester Journal: Sci Rep Date: 2019-04-19 Impact factor: 4.996
Authors: Linda Dieckmann; Marius Lahti-Pulkkinen; Tuomas Kvist; Jari Lahti; Peter E DeWitt; Cristiana Cruceanu; Hannele Laivuori; Sara Sammallahti; Pia M Villa; Sanna Suomalainen-König; Johan G Eriksson; Eero Kajantie; Katri Raikkönen; Elisabeth B Binder; Darina Czamara Journal: Clin Epigenetics Date: 2021-04-29 Impact factor: 6.551
Authors: Astanand Jugessur; Jon Bohlin; Kristine L Haftorn; Yunsung Lee; William R P Denault; Christian M Page; Haakon E Nustad; Robert Lyle; Håkon K Gjessing; Anni Malmberg; Maria C Magnus; Øyvind Næss; Darina Czamara; Katri Räikkönen; Jari Lahti; Per Magnus; Siri E Håberg Journal: Clin Epigenetics Date: 2021-04-19 Impact factor: 6.551
Authors: Xuting Wang; Hye-Youn Cho; Michelle R Campbell; Vijayalakshmi Panduri; Silvina Coviello; Mauricio T Caballero; Deepa Sambandan; Steven R Kleeberger; Fernando P Polack; Gaston Ofman; Douglas A Bell Journal: Clin Epigenetics Date: 2022-04-28 Impact factor: 7.259